Source:http://linkedlifedata.com/resource/pubmed/id/19195497
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-4-7
|
pubmed:abstractText |
The introduction of the WHO FRAX algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. FRAX integrates the influence of several well validated risk factors for fracture with or without the use of BMD. Its use in fracture risk prediction poses challenges for patient assessment, the development of practice guidelines, the evaluation of drug efficacy and reimbursement, as well as for health economics which are the topics outlined in this review.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1873-2763
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
734-43
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
FRAX and its applications to clinical practice.
|
pubmed:affiliation |
WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
|
pubmed:publicationType |
Journal Article,
Review
|